Yeji
PDUFAconf 0.98

et-600 — PDUFA

$ETON · Eton Pharmaceuticals, Inc.
Event date
February 25, 2026
101 days ago
Sponsor runway
cash-flow +
$19.7M liquid

Evidence

“the Company's New Drug Application for ET-600, a proprietary patented formulation of desmopressin oral solution, was accepted for review by the Food and Drug Administration (FDA) and assigned a Prescription Drug User Fee Administration target action date of February 25, 2026.”
Source: 8-K filed 2025-07-08View on EDGAR ↗0001437749-25-022298

Comparable historical pdufas· last 5 years · same event type

75% hit rate (3/4)
TickerDrugDateOutcome
$RCKTkresladi2026-03-28success
$RYTMimcivree2026-03-20success
$CYTKaficamten2025-12-26unknown
$ALDXreproxalap2025-12-16unknown
$BCRXorladeyo2025-12-12success
$OMERnarsoplimab2025-09-25unknown
$BCRXorladeyo (berotralstat)2025-09-12unknown
$ETONet-4002025-05-28unknown
$ALDXreproxalap2025-04-02failure
$IONSolezarsen2024-12-19unknown

Recent insider activity· ±90 days

8 insiders · 0 buys · 0 sells
Exercise
2026-04-21
RIEDEL NORBERT G
Director
12,500 @ $7.31$91K
Exercise
2026-04-21
RIEDEL NORBERT G
Director
19,655 @ $8.61$169K
Opt-Exer
2026-02-03
RIEDEL NORBERT G
Director
30,000 @ $4.42$133K
Tax
2026-01-14
Krempa David
Chief Business Officer
1,942 @ $15.62$30K
Tax
2026-01-14
Gruber James R.
Chief Financial Officer
2,293 @ $15.47$35K
Grant
2026-01-12
CASAMENTO CHARLES J
Director
7,757 @ ——
Grant
2026-01-12
Adams Jennifer McKie
Director
12,196 @ ——
Grant
2026-01-12
Adams Jennifer McKie
Director
7,757 @ ——
Grant
2026-01-12
MAIER PAUL V
Director
12,196 @ ——
Grant
2026-01-12
MAIER PAUL V
Director
7,757 @ ——
Grant
2026-01-12
BRYNJELSEN SEAN
President & CEO
158,046 @ ——
Grant
2026-01-12
BRYNJELSEN SEAN
President & CEO
100,517 @ ——
Grant
2026-01-12
Gruber James R.
Chief Financial Officer
25,856 @ ——
Grant
2026-01-12
RIEDEL NORBERT G
Director
12,196 @ ——
Grant
2026-01-12
RIEDEL NORBERT G
Director
7,757 @ ——
Grant
2026-01-12
Krempa David
Chief Business Officer
40,655 @ ——
Grant
2026-01-12
Gruber James R.
Chief Financial Officer
40,655 @ ——
Grant
2026-01-12
Erdogan-Trinkaus Ipek
Chief Commercial Officer
25,856 @ ——
Grant
2026-01-12
Erdogan-Trinkaus Ipek
Chief Commercial Officer
40,655 @ ——
Grant
2026-01-12
CASAMENTO CHARLES J
Director
12,196 @ ——
Grant
2026-01-12
Krempa David
Chief Business Officer
25,856 @ ——
Tax
2026-01-01
BRYNJELSEN SEAN
President & CEO
5,015 @ $15.39$77K
Tax
2025-12-12
Erdogan-Trinkaus Ipek
Chief Commercial Officer
85 @ $16.90$1K
Tax
2025-12-12
Gruber James R.
Chief Financial Officer
4,542 @ $16.99$77K
Tax
2025-12-12
BRYNJELSEN SEAN
President & CEO
6,732 @ $16.83$113K
Tax
2025-12-12
Krempa David
Chief Business Officer
6,264 @ $17.00$106K
Grant
2025-12-11
Krempa David
Chief Business Officer
5,300 @ ——
Grant
2025-12-11
Gruber James R.
Chief Financial Officer
5,502 @ ——
← All catalysts for $ETON